Plasma 25-hydroxyvitamin D and risk of breast cancer in women followed over 20 years

Experimental evidence supports a protective role of 25-hydroxyvitamin D (25(OH)D) in breast carcinogenesis, but epidemiologic evidence is inconsistent. Whether plasma 25(OH)D interacts with breast tumor expression of vitamin D receptor (VDR) and retinoid X receptor-alpha (RXR) has not been investiga...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Res
Autors principals: Eliassen, A. Heather, Warner, Erica T., Rosner, Bernard, Collins, Laura C., Beck, Andrew H., Quintana, Liza M., Tamimi, Rulla M., Hankinson, Susan E.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5026605/
https://ncbi.nlm.nih.gov/pubmed/27530324
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-16-0353
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars